Amjad Daru Sanat research and production company as a private group in 2019 with the aim of producing specialized drugs in the field of advanced biotechnology based on GMP principles and also the production of chemical drugs succeeded in obtaining its license from the Food and Drug Organization.
Amjad Daru Sanat has started its activity in the field of building a biotechnology pharmaceutical products production plant on a land of 16,000 square meters in Caspian 1 industrial town, which includes the necessary infrastructure for research and development laboratories, production, quality control, assurance It will be a quality and research and technology center.
Amjad Daru Sanat, in order to meet the needs of domestic and foreign patients and provide access to biological drugs with the highest international quality standards, as well as create a job creation platform for graduates and elites interested in the field of pharmaceuticals, is ready to launch protein production lines. Recombination is using eukaryotic cells to produce monoclonal antibodies. These drugs are used as specific and low-complication drugs for the treatment of diseases such as cancer, rheumatoid arthritis, psoriasis, etc., and their use is increasing day by day in the world.
Also, Amjad Daru Sanat is conducting phase 3 clinical studies of hyaluronan-based temperature-sensitive gel containing anti-inflammatory drug for the treatment of osteoarthritis and rheumatoid arthritis as a unique knowledge-based product.
![amjad daru](img/multimedia/content/about.jpg)